CASH FLOW DISCLOSURES AND NON CASH INVESTING AND FINANCING ACTIVITIES (Tables)

9 Months Ended

Sep. 30, 2020

Supplemental Cash Flow Elements [Abstract]

Schedule of cash flow

The following non-cash investing and financing activities occurred during the nine months ended September 30, 2020 and 2019:

	2020		2019
Common Shares issued as part of the Dividend Reinvestment Plan	$	14	$	48
Issuance of share based payments	7,259		12,593
Accrued payables for capital expenditures placed into service	892		3,357
Adjustment to Record Noncontrolling Interest at Redemption Value	(3,196)		488
Adjustment to Record Right of Use Asset & Lease Liability	—		55,515

Schedule of cash and cash equivalents

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows for the nine months ended September 30, 2020 and 2019:

	2020		2019
Cash and cash equivalents	$	13,139	$	31,621
Escrowed cash	7,124		10,540
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$	20,263	$	42,161

Summary of restrictions on cash and cash equivalents

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows for the nine months ended September 30, 2020 and 2019:

	2020		2019
Cash and cash equivalents	$	13,139	$	31,621
Escrowed cash	7,124		10,540
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$	20,263	$	42,161